MESA LABS DECLARES QUARTERLY DIVIDEND
January 04 2024 - 3:00PM
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the
“Company”) today announced that on January 2, 2024 its Board of
Directors declared a regular quarterly dividend of $0.16 per share
of common stock. The dividend will be payable on March 15, 2024, to
shareholders of record at the close of business on February 29,
2024.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and
manufacturing of life science tools and critical quality control
solutions for regulated applications in the pharmaceutical,
healthcare and medical device industries. Mesa offers products and
services to help our customers ensure product integrity, increase
patient and worker safety, and improve the quality of life
throughout the world.
Forward Looking Statements
This press release may contain information that
constitutes forward-looking statements. Forward-looking statements
are subject to risks and uncertainties that could cause actual
results to differ materially from our historical experience and
present expectations or projections. Forward-looking
statements include statements relating to revenues and growth,
operating results, profit margin pressure, industry conditions,
economic conditions, demand, competition, the effects of additional
actions taken to become more efficient or lower costs, risks
related to the integration of acquired businesses, changes in legal
and regulatory matters, the ability to generate additional cash
flow, and the duration and impact of the COVID-19 pandemic and the
myriad of its effects on our business including related decreases
in customer demand and spending, and any events or developments
that we expect or anticipate will occur in the future. Generally,
the words “expect,” “anticipate,” “seek,” “intend,” “plan,”
“believe,” “could,” “estimate,” “may,” “target,” “project,” and
similar expressions identify forward-looking statements. However,
the absence of these words or similar expressions does not mean
that a statement is not forward-looking. These statements are based
upon current information and expectations. Actual results may
differ materially from those estimated or anticipated as a result
of these risks and unknowns or other risks and uncertainties. For
additional information concerning these and other risks and
uncertainties that could affect these statements, and our business,
see our Annual Report on Form 10-K for the year ended March 31,
2023, as well as other risks and uncertainties detailed from time
to time in our reports on Forms 10-Q and 8-K subsequently filed
with the Securities and Exchange Commission. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which speak only as of the date hereof. We undertake no obligation
to republish revised forward-looking statements to reflect events
or circumstances after the date hereof, to provide any updates, or
to reflect the occurrence of future events.
For more information about the Company, please
visit its website at www.mesalabs.com
CONTACT: Gary Owens; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc., +1-303-987-8000
Mesa Laboratories (NASDAQ:MLAB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mesa Laboratories (NASDAQ:MLAB)
Historical Stock Chart
From Jul 2023 to Jul 2024